Hypokalemic myopathy associated with intranasal steroid use (factitious mineralocorticoid excess syndrome.
D000281:Administration, Intranasal; D005162:Factitious Disorders / Q000175:diagnosis*; D005477:Fluprednisolone / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D007008:Hypokalemia / Q000139:chemically induced* / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D009123:Muscle Hypotonia / Q000139:chemically induced; D009132:Muscles / Q000473:pathology; D014663:Nasal Decongestants / Q000009:adverse effects*; D009336:Necrosis; D011782:Quadriplegia / Q000139:chemically induced*
D014663:Nasal Decongestants; C065592:isoflupredone acetate; D005477:Fluprednisolone